Tuberculosis (TB) is the leading infectious cause of death in the world, despite being both preventable and curable. The burden of TB on affected individuals is significant and minority populations are disproportionately impacted. TB treatment is costly and burdensome to individuals, families, communities and Public Health agencies. TB treatment can cause unpleasant and sometimes dangerous side effects, many healthcare visits, isolation from family and friends, and time away from work or school. Most cases of TB in the U.S. can be attributed to latent TB infection (LTBI) that was previously acquired and left untreated.
Through this application, the CDPH TB Program seeks to prevent transmission of TB and reduce morbidity and mortality caused by TB in Chicago by providing comprehensive TB care, conducting thorough contact investigations, diagnosing and treating LTBI among those populations most at risk, and completing examinations of immigrants and refugees. The Program serves as the local TB control authority and, as such, ensures that confirmed TB cases are promptly assessed and reported, possible TB outbreaks are monitored and responded to in a timely manner, and surveillance duties are fulfilled.
During the next project period (2020-2024), the CDPH TB Program will engage community providers in TB prevention and treatment, collaborate with facilities that serve populations at risk for TB and utilize the CDC’s TB Centers of Excellence (COE) as a resource. The Program will monitor its performance against all Division of TB Elimination national indicators to improve its performance and to help guide its activities. All these activities will be done to eventually meet the goal of eliminating TB in the Chicago area.